• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的非运动并发症。

Nonmotor complications of Parkinson disease.

机构信息

Movement Disorders Program, Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Cleve Clin J Med. 2012 Jul;79 Suppl 2:S14-8. doi: 10.3949/ccjm.79.s2a.03.

DOI:10.3949/ccjm.79.s2a.03
PMID:22761264
Abstract

Nonmotor manifestations are integral components of Parkinson disease (PD), and they often have a greater impact on disability and quality of life than the motor features that currently define the illness. Nonmotor features of PD, such as dementia, may be an intrinsic feature of the disorder and persist regardless of the medication state (ie, they continue to manifest in the "on" or "off" state); some nonmotor features, such as psychotic symptoms, may be iatrogenic complications of pharmacologic intervention for the treatment of the motor manifestations of PD. Iatrogenic complications, such as psychosis and impulse control disorders, may respond to modification of the PD treatment regimen at the risk of worsening motor symptoms. Thus, a balance must be struck between controlling nonmotor manifestations and motor features of the disease.

摘要

非运动症状是帕金森病(PD)的固有组成部分,它们比目前定义疾病的运动特征对残疾和生活质量的影响更大。PD 的非运动特征,如痴呆,可能是该疾病的固有特征,并且无论药物状态如何(即,它们在“开”或“关”状态下持续表现);一些非运动特征,如精神病症状,可能是治疗 PD 运动症状的药物干预的医源性并发症。医源性并发症,如精神病和冲动控制障碍,可能需要通过修改 PD 治疗方案来治疗,但可能会恶化运动症状。因此,必须在控制疾病的非运动症状和运动特征之间取得平衡。

相似文献

1
Nonmotor complications of Parkinson disease.帕金森病的非运动并发症。
Cleve Clin J Med. 2012 Jul;79 Suppl 2:S14-8. doi: 10.3949/ccjm.79.s2a.03.
2
[Disorders affecting the emotional sphere and impulse control in Parkinson's disease].[帕金森病中影响情感领域和冲动控制的障碍]
Rev Neurol. 2010 Feb 8;50 Suppl 2:S41-9.
3
Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.帕金森病运动和非运动症状对多巴胺能治疗的反应性。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):57-61. doi: 10.1016/j.pnpbp.2009.09.023. Epub 2009 Sep 28.
4
The impact and management of nonmotor symptoms of Parkinson's disease.帕金森病非运动症状的影响与管理。
Am J Manag Care. 2011 Oct;17 Suppl 12:S308-14.
5
Nonmotor manifestations in Parkinson disease.帕金森病的非运动症状
Neurologist. 2012 Jan;18(1):1-16. doi: 10.1097/NRL.0b013e31823d7abb.
6
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.精神症状及其他非运动症状对帕金森病患者残疾状况的影响。
J Am Geriatr Soc. 2004 May;52(5):784-8. doi: 10.1111/j.1532-5415.2004.52219.x.
7
Nonmotor symptoms in genetic Parkinson disease.遗传性帕金森病的非运动症状
Arch Neurol. 2010 Jun;67(6):670-6. doi: 10.1001/archneurol.67.6.670.
8
Non-motor features of Parkinson's disease: depression and dementia.帕金森病的非运动症状:抑郁和痴呆。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S87-92. doi: 10.1016/S1353-8020(09)70789-8.
9
Neuroimaging of nonmotor features of Parkinson's disease.帕金森病非运动特征的神经影像学
Rev Neurol Dis. 2008 Summer;5(3):125-33.
10
A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia.帕金森病非痴呆患者的神经精神问题概况及其与生活质量的关系
Parkinsonism Relat Disord. 2008;14(1):37-42. doi: 10.1016/j.parkreldis.2007.05.009. Epub 2007 Jul 12.

引用本文的文献

1
Association between herpes zoster and Parkinson's disease and dementia: a systematic review and meta-analysis.带状疱疹与帕金森病和痴呆症之间的关联:一项系统评价和荟萃分析。
Front Neurol. 2024 Dec 5;15:1471736. doi: 10.3389/fneur.2024.1471736. eCollection 2024.
2
Hypomania, Depression, Euthymia: New Evidence in Parkinson's Disease.轻躁狂、抑郁、心境良好:帕金森病的新证据。
Behav Neurol. 2020 Nov 26;2020:5139237. doi: 10.1155/2020/5139237. eCollection 2020.
3
Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy.
多药治疗帕金森病患者的真实队列中的药物安全分析。
CNS Drugs. 2017 Dec;31(12):1093-1102. doi: 10.1007/s40263-017-0478-0.
4
Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.用于帕金森病基因优先级排序的高效且具有生物学相关性的共识策略。
BMC Med Genomics. 2016 Mar 9;9:12. doi: 10.1186/s12920-016-0173-x.
5
Ghrelin and Neurodegenerative Disorders-a Review.胃饥饿素与神经退行性疾病——综述
Mol Neurobiol. 2017 Mar;54(2):1144-1155. doi: 10.1007/s12035-016-9729-1. Epub 2016 Jan 26.
6
Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.长期给予萨索利诺可预防左旋多巴对大鼠行为和神经化学的影响。
Neurotox Res. 2015 May;27(4):399-410. doi: 10.1007/s12640-015-9523-2. Epub 2015 Feb 25.
7
Psychiatric aspects of Parkinson's disease.帕金森病的精神方面
J Neurosci Rural Pract. 2015 Jan;6(1):65-76. doi: 10.4103/0976-3147.143197.
8
An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.在帕金森病诊所环境中使用氯氮平的八年临床经验。
PLoS One. 2014 Mar 19;9(3):e91545. doi: 10.1371/journal.pone.0091545. eCollection 2014.
9
MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348.MitoPark 小鼠,一种帕金森病的动物模型,表现出增强的声起始惊反射的前脉冲抑制作用,并且对腺苷 A(2A)拮抗剂 SCH 412348 的门控反应没有损失。
Psychopharmacology (Berl). 2014 Apr;231(7):1325-37. doi: 10.1007/s00213-013-3320-5. Epub 2013 Oct 23.
10
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.帕金森病的运动前期症状研究:临床和病因学意义。
Environ Health Perspect. 2013 Nov-Dec;121(11-12):1245-52. doi: 10.1289/ehp.1306967. Epub 2013 Aug 9.